Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on BSA. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1197060A reveals p-EBSA purification for valine, leucine, isoleucine. Offers high yield, biodegradable reagents, and scalable manufacturing for pharma supply chains.
Patent CN101367827B details a novel catalytic route for bis(trimethylsilyl)acetamide. This breakthrough ensures superior purity for cephalosporin synthesis and optimized supply chain efficiency.
Metal-free synthesis of alpha-chloroketones from styrenes. Safe, high purity, scalable process for pharmaceutical intermediates manufacturing.
Patent CN111100851B discloses high-efficiency TbSADH mutants for synthesizing chiral biaryl alcohols with >99% ee, offering a green alternative to metal catalysis.
Novel TbSADH mutants enable high-yield synthesis of chiral biaryl alcohols. Efficient biocatalysis for pharmaceutical intermediates with superior stereoselectivity.